These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 16003231
1. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. Hardinger KL, Bohl DL, Schnitzler MA, Lockwood M, Storch GA, Brennan DC. Transplantation; 2005 Jul 15; 80(1):41-6. PubMed ID: 16003231 [Abstract] [Full Text] [Related]
2. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y. Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415 [Abstract] [Full Text] [Related]
3. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. Jones-Hughes T, Snowsill T, Haasova M, Coelho H, Crathorne L, Cooper C, Mujica-Mota R, Peters J, Varley-Campbell J, Huxley N, Moore J, Allwood M, Lowe J, Hyde C, Hoyle M, Bond M, Anderson R. Health Technol Assess; 2016 Aug 27; 20(62):1-594. PubMed ID: 27578428 [Abstract] [Full Text] [Related]
4. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group. Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398 [Abstract] [Full Text] [Related]
5. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC. Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960 [Abstract] [Full Text] [Related]
6. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. Haasova M, Snowsill T, Jones-Hughes T, Crathorne L, Cooper C, Varley-Campbell J, Mujica-Mota R, Coelho H, Huxley N, Lowe J, Dudley J, Marks S, Hyde C, Bond M, Anderson R. Health Technol Assess; 2016 Aug 15; 20(61):1-324. PubMed ID: 27557331 [Abstract] [Full Text] [Related]
7. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, Squifflet JP, Vialtel P, Abramowicz D, Mourad G, Wolf P, Cassuto E, Moulin B, Rifle G, Pruna A, Merville P, Mignon F, Legendre C, Le Pogamp P, Lebranchu Y, Toupance O, Hurault De Ligny B, Touchard G, Olmer M, Purgus R, Pouteil-Noble C, Glotz D, Bourbigot B, Leski M, Wauters JP, Kessler M. Transplantation; 2003 Mar 27; 75(6):844-51. PubMed ID: 12660513 [Abstract] [Full Text] [Related]
8. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. Rathi M, Rajkumar V, Rao N, Sharma A, Kumar S, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Sakhuja V. Transplant Proc; 2015 May 27; 47(4):1158-61. PubMed ID: 26036543 [Abstract] [Full Text] [Related]
9. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I. Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416 [Abstract] [Full Text] [Related]
10. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients. Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M. Transplant Proc; 2005 Nov 27; 37(9):3738-42. PubMed ID: 16386523 [Abstract] [Full Text] [Related]
11. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA. Transplantation; 1996 Dec 15; 62(11):1588-92. PubMed ID: 8970613 [Abstract] [Full Text] [Related]
12. Optimization of the immunosuppressive protocol after lung transplantation. Reichenspurner H, Kur F, Treede H, Meiser BM, Deutsch O, Welz A, Vogelmeier C, Schwaiblmair M, Müller C, Fürst H, Briegel J, Reichart B. Transplantation; 1999 Jul 15; 68(1):67-71. PubMed ID: 10428269 [Abstract] [Full Text] [Related]
13. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W. Liver Transpl; 2008 Feb 15; 14(2):173-80. PubMed ID: 18236391 [Abstract] [Full Text] [Related]
14. Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial. Bösmüller C, Ollinger R, Sieb M, Weissenbacher A, Schneeberger S, Pratschke J, Margreiter R. Ann Transplant; 2012 Dec 31; 17(4):45-51. PubMed ID: 23274323 [Abstract] [Full Text] [Related]
15. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. Treede H, Klepetko W, Reichenspurner H, Zuckermann A, Meiser B, Birsan T, Wisser W, Reichert B, Munich and Vienna Lung Transplant Group. J Heart Lung Transplant; 2001 May 31; 20(5):511-7. PubMed ID: 11343977 [Abstract] [Full Text] [Related]
16. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F. Clin Transplant; 2013 May 31; 27(4):E359-67. PubMed ID: 23710603 [Abstract] [Full Text] [Related]
17. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I. Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404 [Abstract] [Full Text] [Related]
18. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761 [Abstract] [Full Text] [Related]
19. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group. Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208 [Abstract] [Full Text] [Related]
20. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Meiser BM, Groetzner J, Kaczmarek I, Landwehr P, Müller M, Jung S, Uberfuhr P, Fraunberger P, Stempfle HU, Weis M, Reichart B. Transplantation; 2004 Aug 27; 78(4):591-8. PubMed ID: 15446320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]